Baton Rouge, LANCT06933472Now EnrollingIRB Ready

Hyperphosphatemia Clinical Trial in Baton Rouge, LA

Access cutting-edge hyperphosphatemia treatment through this clinical trial at a research site in Baton Rouge. Study-provided care at no cost to qualified participants.

Sponsored by Alebund Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Baton Rouge location

Preparing your pre-screening questions...

Expert Care in Baton Rouge

Access hyperphosphatemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hyperphosphatemia treatment provided free

Apply for This Baton Rouge Location

Check if you qualify for this hyperphosphatemia clinical trial in Baton Rouge, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baton Rouge

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baton Rouge site if eligible
  4. 4Begin participation

About This Hyperphosphatemia Study in Baton Rouge

The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lower blood phosphate levels? * Does AP301 works on serum calcium level, calcium times phosphate level, and intact parathyroid hormone level? * What discomfort or medical problem do the patients have when taking AP301? * Does AP301 improve quality of life in Chinese patients? The researchers will com

Sponsor: Alebund Pharmaceuticals

Who Can Participate

Inclusion Criteria

Provision of signed and dated ICF
Adult when signing the ICF
Patients on dialysis for ≥ 3 months before signing the ICF and throughout the study
For HD patients, spKt/V ≥ 1.2; for PD patients, total Kt/V ≥ 1.7/week
Patients who receive phosphate binders over 4 weeks and their serum phosphate level is: 1. Screening: 1.13 mmol/L (3.5 mg/dL) ≤ serum phosphate \< 2.58 mmol/L (8.0 mg/dL) 2. After washout: 1.94 mmol/L (6.0 mg/dL) ≤ serum phosphate \< 3.23 mmol/L (10.0 mg/dL) Key

Exclusion Criteria

History or plan of kidney transplantation
History or plan of parathyroid intervention 6 months before signing the ICF
Serum calcium \< 1.9 mmol/L (7.6 mg/dL) or \> 2.75 mmol/L (11 mg/dL) at screening
Serum intact parathyroid hormone \> 127 pmol/L (1200 pg/mL) at screening
Presence of clinically significant gastrointestinal (GI) disorder
History of gastrectomy or duodenectomy, or GI surgery within 3 months before signing the ICF
Known allergic

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baton Rouge?

Yes, this clinical trial (NCT06933472) has an active research site in Baton Rouge, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hyperphosphatemia Treatment Options in Baton Rouge, LA

If you're searching for hyperphosphatemia treatment options in Baton Rouge, LA, this clinical trial (NCT06933472) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baton Rouge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hyperphosphatemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hyperphosphatemia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Baton Rouge, LA

See all heart attack clinical trials recruiting in Baton Rouge — not just this study.

Browse Heart Attack Trials in Baton Rouge

Ready to Join in Baton Rouge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baton Rouge, LA